Individual Study / WH-II

Whitehall II

Whitehall II

Networks -
Datasets -
Variables -
Start Year
1985
Supplementary Information

The Whilehall II study is a member of the following networks:

-       HALCyon (Healthy Ageing across the Life Course)

-       ERFC  (Emerging Risk Factors Collaboration)

-       IPD-Work Consortium ("Individual-participant-data meta-analysis of working populations")

-       LEAD Consortium (Leadership in Epidemiological Analysis of longitudinal Diabetes-related data)

-       IL6R MR Consortium (Interleukin-6 Receptor Mendelian Randomisation Analysis)

-       ICBP (International Consortium for Blood Pressure) 

Visit WH-II

Members

Download
Investigators Contacts
  • Prof. Mika Kivimaki
    University College London
  • Prof. Eric Brunner
    University College London
  • Dr. Archana Singh-Manoux
    University College London
  • Dr. Tindie Kalsi
    University College London

Design

Study design
Cohort
Follow Up

The whole cohort has been invited to fill in a comprehensive self-completion questionnaire and to attend the research clinic at 5-year intervals, which has been reduced to a 3-years interval from 2012. A postal self-completion questionnaire was sent to participants between clinic phases up to 2006. 

Supplementary Information

Marker Paper

Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol. 2005 Apr;34(2):251-6. Epub 2004 Dec 2.

PUBMED 15576467

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
10,308
Number of Participants with Biological Samples
10,308

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Timeline

Whitehall II population

Selection Criteria
Minimum age
35
Maximum age
55
Newborns
Twins
Countries
  • United Kingdom
Territory

Central London, England.

Ethnic Origin
Health Status

Recruitment

Sources of recruitment
  • General population
General Population
  • Volunteer enrolment
Participants from Existing Studies

Number of Participants

Number of Participants
10,308
Number of Participants with Biological Samples
Supplementary Information about selection criteria

Phase 1: 10 308 participants (3413 women and 6895 men)

Phase 2: 8132 participants

Phase 3: 8815 participants

Phase 4: 8628 participants

Phase 5: 7870 participants

Phase 6: 7355 participants

Phase 7: 6967 participants

Phase 8: 7173 participants

Phase 9: 6761 participants

Phase 10: 277 participants

Phase 11: 6318 participants

Data Collection Events
# Name Description Start End
0 Phase 1

Clinic visit for medical examination and completion of a full questionnaire. Brief telephone questionnaire was administered to those who declined clinic and full questionnaire. n= 10308

1985 1988
1 Phase 2

Follow up of participants by postal questionnaire. n=8132.

1989 1990
2 Phase 3

Clinic visit for medical examination and completion of a full questionnaire. Brief telephone questionnaire was administered to those who declined clinic and full questionnaire. n= ...

1991 1994
3 Phase 4

Follow up of participants by postal questionnaire. n=8628.

1995 1996
4 Phase 5

Clinic visit for medical examination and completion of a full questionnaire. Brief telephone questionnaire was administered to those who declined clinic and full questionnaire. n= ...

1997 1999
5 Phase 6

Follow up of participants by postal questionnaire. n=7355.

2001 2001
6 Phase 7

Clinic visit for medical examination and completion of a full questionnaire. Brief telephone questionnaire was administered to those who declined clinic and full questionnaire. Home ...

2002 2004
7 Phase 8

Follow up of participants by postal questionnaire. n=7173.

2006 2006
8 Phase 9

Clinic visit for medical examination and completion of a full questionnaire. Brief telephone questionnaire was administered to those who declined clinic and full questionnaire. Home visit by ...

2007 2009
9 Phase 10 (pilot)

A small group of Stress and Health participants were selected randomly and invited to attend the Phase 10 clinic.

2011-02 2011-03
10 Phase 11

Clinic visit for medical examination and completion of a full questionnaire. Brief telephone questionnaire was administered to those who declined clinic and full questionnaire. Home visit by ...

2012 2013

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments
Life events
Beliefs and values
Perception of health
Quality of life
Life course development
Functional limitations
Other perception of health, quality of life and functional limitation-related information
Tobacco
Alcohol
Drugs
Nutrition
Breastfeeding
Physical activity
Sleep
Sexual behaviours and orientation
Technological devices
Misbehaviour and criminality
Other and unspecified lifestyle information
Social network
Social participation
Social support
Parenting and familial environment
Other social environment characteristics

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Marital/partner status
Family and household structure
Education
Labour force and retirement
Income, possessions, and benefits
Other socio-demographic and economic characteristics

Lifestyle and behaviours

Tobacco
Alcohol
Nutrition
Physical activity
Transportation
Sleep
Leisure activities
Other and unspecified lifestyle information

Birth, pregnancy and reproductive health history

Puberty, menstruation, menopause and andropause
Contraception
Pregnancy, delivery and birth

Perception of health, quality of life, development and functional limitations

Perception of health
Quality of life
Functional limitations
Use of assistive devices

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Endocrine, nutritional and metabolic diseases (E00-E90)
Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the eye and adnexa (H00-H59)
Diseases of the ear and mastoid process (H60-H95)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the skin and subcutaneous tissue (L00-L99)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Diseases of the genitourinary system (N00-N99)
Injury, poisoning and certain other consequences of external causes (S00-T98)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
Symptoms and signs involving the digestive system and abdomen (R10-R19)
Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
Symptoms and signs involving speech and voice (R47-R49)
General symptoms and signs (R50-R69)
Symptoms related to multiple categories

Medication and supplements

Medication and supplement intake

Non-pharmacological interventions

Surgical interventions
Radiological interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Visits to health professionals
Hospitalizations

Death

Vital status
Cause of death

Physical measures and assessments

Anthropometry
Circulation and respiration
Muscles, skeleton and mobility
Other physical measures and assessments

Laboratory measures

Hematology
Biochemistry
Immunology

Cognition, personality and psychological measures and assessments

Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments

Life events, life plans, beliefs and values

Life events
Life plans
Beliefs and values

Preschool, school and work life

Work life

Social environment and relationships

Social network
Social participation
Social support
Parenting and familial environment
Other social environment characteristics

Physical environment

Housing characteristics
Built environment/neighbourhood characteristics
Workplace characteristics
Radiation exposure
Chemical exposure
Biological exposure
Other physical environment characteristics

Administrative information

Identifiers
Date and time-related information
Questionnaire and interview-related information
Physical and cognitive measure and biosample-related information
Data and sample collection center-related information
Other administrative information

Cognitive functioning

AH4 Group Test of General Intelligence
Category Fluency Test
Letter Fluency Test
Mini-Mental State Examination
Mill Hill Vocabulary Scale

Personality

Adult Attachment Scale
Cook-Medley Hostility Scale
MacArthur Reactive Responding Scale

Psychological distress and emotions

Bradburn Affect Balance Scale
Center for Epidemiological Studies Depression Scale
General Health Questionnaire
Positive and Negative Affect Schedule
Spielberger State-Trait Anger Expression Inventory

Other psychological measures and assessments

Somatosensory Amplification Scale

Beliefs and values

Beck Hopelessness Scale
Negatively Worded Brief Measure of Hopelessness
Perceived Control Scale

Quality of life

CASP-19 Quality of Life Scale
Life Satisfaction Questionnaire
Short-Form 36 Health Survey
Satisfaction with Life Scale

Functional limitations

Activities of Daily Living
Instrumental Activities of Daily Living

Tobacco

Fagerström Test for Nicotine Dependence

Alcohol

CAGE Questionnaire

Nutrition

Food Frequency Questionnaire (different forms)

Social support

Non-Reciprocal Social Relations Questionnaire
UCLA Loneliness Scale

Other social environment characteristics

Work-Family Spillover Scale